Home
Conditions
Neoplasms, Unknown Primary

Clinical trial condition

Neoplasms, Unknown Primary

Explore clinical trials studying Neoplasms, Unknown Primary. Study availability and eligibility vary by location and protocol.

75 public trials 13 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Unknown Primary trial results

Active, not recruiting

Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers

NCT04459273

Conditions: Adenocarcinoma, Adrenal Gland Diseases, Adrenal Gland Neoplasms, +77 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Active, not recruiting

Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors

NCT04802876

Conditions: Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenocarcinoma of Lung, +111 more
Locations: Grupo SOLTI Barcelona, Spain

View Trial Details

Active, not recruiting

Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics

NCT04584008

Conditions: Biliary Tract Diseases, Biliary Tract Neoplasms, Carcinoma, +42 more
Locations: Peking University Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

HARE-40: HPV Anti-CD40 RNA vaccinE

NCT03418480

Conditions: Cervical Neoplasm, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +26 more
Locations: Univeristy Hospitals Southampton NHS Foundation Trust Southampton, Hampshire, United Kingdom

The Christie NHS Foundation Trust Manchester, United Kingdom

View Trial Details

Completed

Pembrolizumab in Patients With Poor-Prognosis Carcinoma of Unknown Primary Site (CUP)

NCT03391973

Conditions: Carcinoma of Unknown Primary, Neoplasm Metastasis, Neoplasms, +4 more
Locations: Tom Baker Cancer Centre Calgary, Alberta, Canada

Cross Cancer Institute Edmonton, Alberta, Canada

Ottawa Hospital Cancer Centre Ottawa, Ontario, Canada

View Trial Details

Completed

A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy

NCT01624220

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +60 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Trial of Pembrolizumab in Cancer of Unknown Primary

NCT03752333

Conditions: Cancer of Unknown Primary Site, Carcinoma, Neoplasm Metastasis, +7 more
Locations: Hammersmith Hospital - Imperial College Healthcare NHS Trust Hammersmith, London, United Kingdom

Gastrointestinal Units, The Royal Marsden NHS Foundation Trust (Sutton and Chelsea) Sutton, Surrey, United Kingdom

Guy's Cancer Centre, Guy's and St Thomas' NHS Foundation Trust London, United Kingdom

View Trial Details

Completed

Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)

NCT05461430

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +139 more
Locations: xCures Oakland, California, United States

View Trial Details

Completed

Sintilimab in Cancer of Unknown Primary

NCT05024968

Conditions: Cancer of Unknown Primary Site, Neoplasm Metastasis, Neoplasms, +4 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

A Phase II Randomized Study Comparing the Efficacy and Safety of Targeted Therapy or Cancer Immunotherapy Versus Platinum-Based Chemotherapy in Patients With Cancer of Unknown Primary Site

NCT03498521

Conditions: Cancer of Unknown Primary Site, Neoplasm Metastasis, Neoplasms, +4 more
Locations: Blacktown Hospital Blacktown, New South Wales, Australia

GenesisCare North Shore St Leonards, New South Wales, Australia

Icon Cancer Foundation South Brisbane, Queensland, Australia

Lkh-Univ. Klinikum Graz Graz, Austria

View all 125 locations

View Trial Details

Neoplasms, Unknown Primary

Neoplasms, Unknown Primary trial results

Related conditions